Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

November 1, 2017

Open Enrollment for Marketplace and Medicare Plans

  • Misc. MS Related
    /
  • National MS Society Related
    /
October 13, 2017 Each year, open enrollment periods provide time to review your options and make sure you’re enrolled in…
Misc. MS Related

November 1, 2017

Patient Survey Studies Find Multiple Sclerosis Relapse is Underreported; Approximately Half of Patients Do Not Always Engage with Healthcare Practitioners During Relapse

  • MS Relapse
    /
  • MS Relapse-Exacerbation
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
— Mallinckrodt-Sponsored Survey Findings Presented at 7th Joint ECTRIMS-ACTRIMS Meeting (MSParis2017) — STAINES-UPON-THAMES, United Kingdom, Oct. 27, 2017 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a…
MS Relapse

October 28, 2017

Novartis PARADIGMS data show children and adolescents with MS had an 82% lower relapse rate with Gilenya® vs. interferon beta-1a

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Pediatric MS
    /
OCT 28, 2017 PARADIGMS data also show patients treated with Gilenya had significantly fewer new brain lesions vs. those on…
MS Drug Therapies

October 28, 2017

New OCREVUS (Ocrelizumab) Data at ECTRIMS Advance Clinical Understanding of Underlying Progression in Multiple Sclerosis

  • MS Drug Therapies
    /
  • Ocrevus
    /
·       Data show superiority of OCREVUS compared to Rebif (interferon beta-1a) in significantly reducing disability Progression Independent of Relapse Activity…
MS Drug Therapies

October 26, 2017

Biomarkers Aid in Diagnosis, Prognosis of Early Multiple Sclerosis

  • Multiple Sclerosis
    /
OCTOBER 11, 2017 Ellen Kurek No specific biochemical markers have been available to confirm the diagnosis of multiple sclerosis (MS) – until…
Multiple Sclerosis

October 26, 2017

Preliminary Results of MS Prevalence Study Estimate Nearly 1 Million Living with MS in the U.S.

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
NEWS release from The National Multiple Sclerosis Society October 26, 2017 In a study presented this week at ECTRIMS—the world’s…
MS Research Study and Reports

October 26, 2017

Pediatric MS Center information updated

  • Multiple Sclerosis
    /
  • Pediatric MS
    /
Pediactric MS Centers Doctors and Specialists For a listing of USA pediatric MS Centers,  please click here MS Views and…
Multiple Sclerosis

October 26, 2017

Excerise…. a Must for both, the MS patient to partake in doing and healthcare providers to promote

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
10.25.17 –  by:  Jeffrey A. Segal, BS, NSCA-CPT, CSCS, CPTS, CPR/AED                    …
Alternative therapies and devices for Multiple Sclerosis (MS)

October 24, 2017

Multiple Sclerosis Risk Significantly Associated With Vitamin D Deficiency

  • Multiple Sclerosis
    /
  • Vitamins and Supplements
    /
Vitamin D deficiency represents a significant risk factor for multiple  sclerosis (MS), necessitating the need for greater public outreach and interventions to…
Multiple Sclerosis

October 24, 2017

Managing Urinary Retention in Multiple Sclerosis

  • Multiple Sclerosis
    /
  • Urologic Symptoms
    /
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, resulting in a variety of nonspecific…
Multiple Sclerosis

Categories

Latest Blog Posts